Moreover, a human breast cancer cell study shows that estrogens can bind to estrogen receptor alpha (ERα), interacting with the Smad complex to facilitate its degradation resulting in the inhibition of TGF-β signaling and thereby exerting anti-fibrotic effects [134]. Here, ESR1 is linked to breast carcinoma.